stockportfolio.pro
TG Therapeutics, Inc. Shares Outstanding 2011–2025
TG Therapeutics, Inc. (TGTX) annual shares outstanding by fiscal year, computed from SEC filings. Compound growth +27.7%/yr over 14 years.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 155.3M | -0.3% |
| FY 2024 | 155.8M | +2.9% |
| FY 2023 | 151.4M | +3.4% |
| FY 2022 | 146.4M | +2.2% |
| FY 2021 | 143.3M | +1.9% |
| FY 2020 | 140.6M | +28.5% |
| FY 2019 | 109.4M | +30.4% |
| FY 2018 | 83.9M | +14.7% |
| FY 2017 | 73.1M | +28.8% |
| FY 2016 | 56.8M | +5.0% |
| FY 2015 | 54.1M | +20.3% |
| FY 2014 | 44.9M | +31.0% |
| FY 2013 | 34.3M | +32.9% |
| FY 2012 | 25.8M | +409.9% |
| FY 2011 | 5.1M | — |
Source: TG Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s shares outstanding?
TG Therapeutics, Inc. (TGTX) reported shares outstanding of 155.3M for fiscal year 2025, per its SEC filings.
How has TG Therapeutics, Inc.'s shares outstanding changed over time?
Between fiscal 2011 and 2025, TGTX's shares outstanding grew at roughly 27.7% per year (compound annual rate), from 5.1M to 155.3M.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.